Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 23, 2017

DrugPatentWatch Database Preview

FENTANYL CITRATE Drug Profile

« Back to Dashboard

What is the patent landscape for Fentanyl Citrate, and when can generic versions of Fentanyl Citrate launch?

Fentanyl Citrate is a drug marketed by Mallinckrodt, Par Pharm, Hospira, Abbott, Watson Labs, Astrazeneca, West-ward Pharms Int, and Watson Labs Inc. and is included in fourteen NDAs.

The generic ingredient in FENTANYL CITRATE is droperidol; fentanyl citrate. There are five drug master file entries for this compound. Additional details are available on the droperidol; fentanyl citrate profile page.

Summary for Tradename: FENTANYL CITRATE

Patents:0
Applicants:8
NDAs:14
Suppliers / Packagers: see list5
Bulk Api Vendors: see list16
Clinical Trials: see list559
Patent Applications: see list1,749
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:FENTANYL CITRATE at DailyMed

Pharmacology for Tradename: FENTANYL CITRATE

Drug ClassOpioid Agonist
Mechanism of ActionFull Opioid Agonists
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira
FENTANYL CITRATE PRESERVATIVE FREE
fentanyl citrate
INJECTABLE;INJECTION072786-001Sep 24, 1991APRXNoNo► Subscribe► Subscribe
Mallinckrodt
FENTANYL CITRATE
fentanyl citrate
TROCHE/LOZENGE;TRANSMUCOSAL078907-001Oct 30, 2009ABRXNoNo► Subscribe► Subscribe
Watson Labs
FENTANYL CITRATE
fentanyl citrate
TABLET;BUCCAL, SUBLINGUAL079075-003Jan 7, 2011DISCNNoNo► Subscribe► Subscribe
Astrazeneca
FENTANYL CITRATE AND DROPERIDOL
droperidol; fentanyl citrate
INJECTABLE;INJECTION072028-001Apr 13, 1989DISCNNoNo► Subscribe► Subscribe
Par Pharm
FENTANYL CITRATE
fentanyl citrate
TROCHE/LOZENGE;TRANSMUCOSAL077312-001Oct 30, 2009ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Formulary management
  • Obtain formulation and manufacturing information
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot